The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| GDNS.F | +41.2% | -41.15% | -10.06% | -87% |
| S&P | +18.54% | +92.9% | +14.04% | +142% |
Goodness Growth Holdings, Inc. engages in the business of operating cannabis cultivation, production, and dispensary facilities, and manufacturing cannabis products in environmentally friendly greenhouses. It operates through the following product segments: Inhalable, Ingestible, and Topicals. The Inhalable segment includes flower and trim, dabbable concentrates, distillate pre-filled vaporizer pens, cartridges, pre-rolls, and distillate syringes. The Ingestible segment focuses on edibles, tablets, softgels, oral solutions, oral spray, tinctures, and lozenges. The Topicals segment offers balms and topical bars. The company was founded by Kyle E. Kingsley on November 23, 2004 and is headquartered in Minneapolis, MN.
Vireo Health, now Goodness Growth, has some ambitious goals for the next 18 months.
The co-founder and former CEO of Canopy Growth has a lot to say about his new SPAC, how the election will change the cannabis industry, and electric vehicles.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $48.06M | 91.4% |
| Gross Profit | $19.32M | 45.3% |
| Gross Margin | 40.19% | -12.8% |
| Market Cap | $154.26M | 133.7% |
| Market Cap / Employee | $0.30M | 0.0% |
| Employees | 520 | 6.1% |
| Net Income | -$14.93M | -2134.3% |
| EBITDA | $3.81M | -36.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $106.19M | 845.6% |
| Accounts Receivable | $9.14M | 60.5% |
| Inventory | 63 | 213.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $135.30M | 347.0% |
| Short Term Debt | $30.83M | -50.6% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -9.85% | -0.3% |
| Return On Invested Capital | -160.84% | 10.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$7.70M | -143.5% |
| Operating Free Cash Flow | -$3.95M | -376251.1% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -3.04 | -11.72 | 3.03 | 3.06 | -204.61% |
| Price to Tangible Book Value | -2.22 | -6.75 | 3.53 | 3.61 | -269.99% |
| Return on Equity | -141.7% | -199.6% | -34.2% | - | |
| Total Debt | $78.28M | $90.09M | $90.06M | $166.13M | 79.16% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
